2012 Program

Wednesday, March 7, 2012
6:30PM – 8:30PM Business Development Reception Hosted by BayBio & BIOCOM Chairs & Boards of Directors
Invitation Only Event
Thursday, March 8, 2012
7:00AM – 8:30AM Registration and Networking Breakfast
8:30AM – 9:45AM
The Honorable Ed Lee, Mayor, City and County of San Francisco
Opening Keynote
“A Perspective on Risk”Andrew C. von Eschenbach, MD
Former Commissioner, FDA
President, Samaritan Health Initiatives

Steve Walker
Co-Founder, The Abigail Alliance for Better Access to Developmental Drugs

Andrew C. von Eschenbach, M.D.

von Eschenbach

Steve Walker


Track 1
Capital Access
Track 2
Clinical Development
Track 3
Track 4
10:00AM – 11:15AM Session 1 New Developments in VC Financings – Selling Your Soul? Patient Advocacy: The Key to the Next Evolution of Clinical Development Reimbursement: Will They Pay? The Changing Role of Payers in a Product’s Success 10:00AM – 10:20AM
The Myelin Repair Foundation

10:25AM – 10:45AM
The Michael J. Fox Foundation

10:50AM – 11:10AM
Fast Forward

Partnering Exhibits
11:15AM – 11:45AM Coffee Break
11:45AM – 1:00PM Session 2 Successful Collaborations with Passion Investors Ten Tips to Accelerate Clinical Trials and Do Them Well The Biotech Product Launch: Not Necessarily Destined for Failure 11:45AM – 12:05PM
EveryLife Foundation

12:15PM – 12:25PM
Melanoma Research Alliance

12:30PM – 12:50PM

1:00PM – 1:30PM Lunch
1:30PM – 2:45PM
Luncheon Keynote
“The Power of Patient Driven Medicine: When Drug Research is Personal”John F. Crowley
Chairman, President and CEO, Amicus Therapeutics, Inc
John F. Crowley


2:45PM – 4:00PM Session 3 Before You Look for Loose Change: Alternative Funding Sources for Biotech and How to Secure Them Emerging Issues in the Conduct of Global Clinical Trials Flexing Commercial Muscle Beyond the US 2:45PM – 3:05PM

3:10PM – 3:30PM
The Leukemia & Lymphoma Society

3:35PM – 3:55PM
Critical Path Institute

4:00PM – 4:15PM Coffee Break
4:15PM – 5:30PM Session 4 Preparing for M&A: Engineering a Happy Marriage Modernizing our Industry: Developing the Clinical Trials of the Future Orphan and Ultra Orphan Drugs: Market Experiences & Opportunities 4:15PM – 4:35PM
Partnership for Compassionate Use Therapies (PCUT)

4:40PM – 5:00PM
Alzheimer’s Association

5:30PM – 7:00PM Opening Night Reception
Friday, March 9, 2012
7:30AM – 8:15AM Registration and Networking Breakfast Partnering Exhibits
8:15AM – 9:30AM
The Honorable Jerry Hill, California State Assembly
Opening Keynote
“A Reordering is in the Works”George A. Scangos, PhD
CEO, Biogen Idec
George A. Scangos, PhD


Track 1
Drug Discovery
Track 2
Track 3
Track 4
Business Models
9:45AM – 11:00AM Session 1 The Innovators Dilemma – How do we Reinvent the Life Sciences R&D Model Regulatory Risk: How Do We Manage? Taking Matters into Their Own Hands: The Role of Patients in Drug Development Life Sciences Innovation: A Fundable Future or Financial Flop?
11:00AM – 11:30AM Coffee Break
11:30AM – 12:45PM Session 2 Now for Something Completely Different: How will Pharma Access External Early-Stage Innovation? Coverage and Reimbursement Risks: The Influence of Deficit Reduction and Other Pressures Patient Access to Developmental Drugs Blueprint for Success: Which Biotech Business Model Works Best for You?
12:45PM – 1:15PM Lunch
1:15PM – 2:30PM
Special Guest
Governor Jerry Brown
Luncheon Keynote
“Achieving Industry Goals in an Election Year”Moderator:
James Greenwood
President and CEO, Biotechnology Industry Organization (BIO)

Plenary Speaker:
Brian Bilbray
U.S. Representative, California’s 50th Congressional District

James Greenwood


Brian Billbray


2:30PM – 3:45PM Session 3 Leading Edge Tools, Technologies and Approaches for Drug Discovery Regulating Diagnostics: Anticipating the Path Forward Social Media and Life Sciences: Hearing a Patient’s Voice Biotech Then and Now: What Does Biotech Look Like 10 Years from Now? Partnering
3:45PM – 5:00PM Closing Reception